Your browser doesn't support javascript.
loading
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
Mai, Hai-Qiang; Chen, Qiu-Yan; Chen, Dongping; Hu, Chaosu; Yang, Kunyu; Wen, Jiyu; Li, Jingao; Shi, Yingrui; Jin, Feng; Xu, Ruilian; Pan, Jianji; Qu, Shenhong; Li, Ping; Hu, Chunhong; Liu, Yi-Chun; Jiang, Yi; He, Xia; Wang, Hung-Ming; Lim, Wan-Teck; Liao, Wangjun; He, Xiaohui; Chen, Xiaozhong; Wang, Siyang; Yuan, Xianglin; Li, Qi; Lin, Xiaoyan; Jing, Shanghua; Chen, Yanju; Lu, Yin; Hsieh, Ching-Yun; Yang, Muh-Hwa; Yen, Chia-Jui; Samol, Jens; Luo, Xianming; Wang, Xiaojun; Tang, Xiongwen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Xu, Rui-Hua.
Afiliación
  • Mai HQ; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou.
  • Chen QY; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou.
  • Chen D; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Hu C; Fudan University Cancer Center, Shanghai, China.
  • Yang K; Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China.
  • Wen J; Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Li J; Jiangxi Cancer Hospital, Nanchang, China.
  • Shi Y; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China.
  • Jin F; The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.
  • Xu R; Shenzhen People's Hospital, Shenzhen, China.
  • Pan J; Fujian Provincial Cancer Hospital, Fuzhou, China.
  • Qu S; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Li P; West China Hospital of Sichuan University, Chengdu.
  • Hu C; The Second Xiangya Hospital of Central South University, Changsha, China.
  • Liu YC; Taichung Veterans General Hospital, Taichung, Taiwan.
  • Jiang Y; Cancer Hospital of Shantou University Medical College, Shantou, China.
  • He X; Jiangsu Cancer Hospital, Nanjing, China.
  • Wang HM; Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Lim WT; National Cancer Centre, Singapore City, Singapore.
  • Liao W; Nanfang Hospital, Guangzhou, China.
  • He X; Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
  • Chen X; Zhejiang Cancer Hospital, Hangzhou, China.
  • Wang S; The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
  • Yuan X; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li Q; Shanghai General Hospital, Shanghai, China.
  • Lin X; Fujian Medical University Union Hospital, Fuzhou, China.
  • Jing S; The Fourth Hospital of Hebei Medical University Hebei Cancer Hospital, Shijiazhuang, China.
  • Chen Y; Hainan General Hospital, Haikou, China.
  • Lu Y; Liuzhou Worker's Hospital, Liuzhou, China.
  • Hsieh CY; China Medical University Hospital, Taichung, Taiwan.
  • Yang MH; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Yen CJ; National Cheng Kung University Hospital, Tainan, Taiwan.
  • Samol J; Tan Tock Seng Hospital, Singapore City, Singapore.
  • Luo X; Shanghai Junshi Biosciences, Shanghai, China.
  • Wang X; Shanghai Junshi Biosciences, Shanghai, China.
  • Tang X; TopAlliance Biosciences, Rockville, Maryland.
  • Feng H; Shanghai Junshi Biosciences, Shanghai, China.
  • Yao S; TopAlliance Biosciences, Rockville, Maryland.
  • Keegan P; Shanghai Junshi Biosciences, Shanghai, China.
  • Xu RH; TopAlliance Biosciences, Rockville, Maryland.
JAMA ; 330(20): 1961-1970, 2023 11 28.
Article en En | MEDLINE | ID: mdl-38015220
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Cisplatino / Anticuerpos Monoclonales Humanizados / Carcinoma Nasofaríngeo / Gemcitabina / Antineoplásicos País/Región como asunto: America do norte Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Cisplatino / Anticuerpos Monoclonales Humanizados / Carcinoma Nasofaríngeo / Gemcitabina / Antineoplásicos País/Región como asunto: America do norte Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos